Home » Topics » Regulatory

Regulatory
RSS

FDA clears new formulation of Imitrex

Sep. 1, 1997

First approval for irbesartan

Sep. 1, 1997

New indication approved for Asacol

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Living human tissue approved for marketing in Canada

Aug. 22, 1997

Supplemental NDA approved for Cipro

Aug. 22, 1997

Infanrix Hep B approved in all EU countries

Aug. 19, 1997

Twinrix now available for pediatric use

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...